Yoshimatsu K, Kono T, Satake M, Ito Y, et al. Poor Prognosis in Patients With Stage III Colorectal Cancer Receiving Adjuvant FOLFOX/CAPOX Therapy Is Predicted by the Presence of Many Poorly Differentiated Clusters. Anticancer Res 2023;43:3235-3240.
PMID: 37352004